Brief: RenovoRx Reports Q1 2022 Financial Results
16/05/2022 13:17
May 16 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* RENOVORX INC - CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2022,
WERE $13.1 MILLION.
Source text for Eikon: ID:nBw8TYP8Ba
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer